INDIANAPOLIS--Eli Lilly and Company has agreed to pay a 36-million dollar fine.
The Indianapolis company has announced that it has settled with the Justice Department over a charge that it violated Federal Law in promoting "Evista" (that's Lilly's osteoporosis drug).
The firm says certain employees promoted Evista as a treatment for breast cancer and cardiovascular risk reduction.
Lilly is now testing the drug for those applications, but the FDA hasn't yet approved them.
Lilly officials dispute some allegations in the government's case but won't fight them.
Have a question or comment about a news story? Send it to email@example.com